**Core Concept**
In this scenario, the patient has a history of Systemic Lupus Erythematosus (SLE), a chronic autoimmune disease that can affect multiple organs, including the skin, joints, kidneys, and nervous system. The presence of Venereal Disease Research Laboratory (VDRL) test positivity indicates a potential diagnosis of syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum.

**Why the Correct Answer is Right**
The patient's pregnancy status and SLE history necessitate careful consideration to avoid any potential harm to the fetus or the mother. Treating syphilis in pregnancy is crucial to prevent congenital syphilis, which can cause severe birth defects and even fetal death. The recommended treatment for syphilis in pregnancy is intravenous penicillin G, which is effective in clearing the infection and preventing transmission to the fetus.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the patient's syphilis infection, which requires prompt treatment. Delaying treatment can lead to worsening of the disease and potential transmission to the fetus.
**Option B:** This option is incorrect because it does not account for the patient's SLE history, which may require careful consideration of medications to avoid exacerbating the disease. Additionally, SLE patients may require closer monitoring during pregnancy.
**Option C:** This option is incorrect because it only addresses the SLE management without considering the syphilis infection. Treating syphilis is crucial in this scenario, and managing SLE is secondary.

**Clinical Pearl / High-Yield Fact**
In pregnant patients with SLE, it is essential to consider the potential teratogenic effects of medications and choose treatments that minimize fetal risk. This includes avoiding medications like warfarin and choosing alternative anticoagulants like low molecular weight heparin.

**Correct Answer: D. Intravenous penicillin G is the recommended treatment for syphilis in pregnancy.**